The mechanism involved behind the antitumor activity is retardation of cyclooxygenase enzymes, the proliferation of tumor cells, and lipid peroxidation by inhibiting the activation of nuclear factor-κβ (NF-κβ) at the genetic level (187). Here, NFKB1 is linked to neoplasm.